Dr. Joseph Gligorov is a medical oncologist who currently holds the position of Professor of Medical Oncology at Sorbonne University and practices as a physician in the Medical Oncology Department at Tenon Hospital in Paris (APHP). He is also an integral member of INSERM U938 “Cancer Biology and Treatments” team. Currently, Dr. Gligorov serves as the Executive Director of the APHP–Sorbonne University Cancer Institute.

Dr. Gligorov’s main areas of clinical and translational research are breast cancer and the study of predictive factors for patient response to anticancer treatments. His expertise extends beyond direct patient care; he actively contributes to the development of national cancer treatment strategies as a member of various dedicated working groups. He also oversees the organization of the Nice–St Paul de Vence conference, which focuses on developing guidelines for breast cancer treatment.

In addition, Dr. Gligorov co-founded and presides over the Mediterranean Association for Radiation Oncology and Medical Oncology (AROMe). This organization aims to improve care for cancer patients, facilitate access to innovative treatments, and promote oncology education in emerging countries of the Mediterranean region.